New LaunchJul 21, 2026, 09:08 AM
Myriad Genetics Launches FirstGene Multiple Prenatal Screen
AI Summary
Myriad Genetics has announced the full commercial launch of its FirstGene® Multiple Prenatal Screen. This innovative test is the only lab solution that simultaneously performs four prenatal genetic screens from a single blood draw, as early as eight weeks gestation. With results expected in about 10 days, FirstGene aims to streamline the prenatal screening process and provide clinicians with actionable insights earlier in pregnancy, expanding the company's comprehensive prenatal screening portfolio.
Key Highlights
- Myriad Genetics announced the full commercial launch of FirstGene® Multiple Prenatal Screen.
- FirstGene is the only lab test to run four prenatal genetic screens simultaneously from a single blood draw.
- The test can be performed as early as eight weeks gestation.
- Results are expected to be delivered in approximately 10 days.
- The screen boasts greater than 98% analytical sensitivity and 99% analytical specificity.
- It integrates fetal chromosome, fetal single-gene, patient carrier, and fetal RhD screens.
- The launch expands Myriad Genetics' comprehensive prenatal screening portfolio.
Price Impact
More from MYGN